Federated Hermes, Inc. Kaleido Biosciences, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.05 - $1.7 $30,384 - $1.03 Million	-607,687 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.3 - $2.7 $1,929 - $4,006	1,484 Added 0.24%	607,687 $1 Million
Q4 2021 Feb 14, 2022	SELL	$2.39 - $6.02 $522,924 - $1.32 Million	-218,797 Reduced 26.52%	606,203 $1.45 Million
Q1 2021 May 13, 2021	BUY	$7.2 - $16.82 $2.34 Million - $5.47 Million	325,000 Added 65.0%	825,000 $6.68 Million
Q2 2020 Aug 13, 2020	BUY	$4.62 - $8.01 $2.31 Million - $4.01 Million	500,000 New	500,000 $3.72 Million

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.